{"id":11348,"date":"2012-03-06T00:00:00","date_gmt":"2012-03-05T23:00:00","guid":{"rendered":"https:\/\/idibell.cat\/es\/blog\/2012\/03\/06\/el-idibell-participa-en-un-proyecto-europeo-para-detectar-y-prevenir-la-diabetes-de-tipo-2\/"},"modified":"2023-03-02T14:51:52","modified_gmt":"2023-03-02T13:51:52","slug":"el-idibell-participa-en-un-proyecto-europeo-para-detectar-y-prevenir-la-diabetes-de-tipo-2","status":"publish","type":"post","link":"https:\/\/idibell.cat\/es\/2012\/03\/el-idibell-participa-en-un-proyecto-europeo-para-detectar-y-prevenir-la-diabetes-de-tipo-2\/","title":{"rendered":"El IDIBELL participa en un proyecto europeo para detectar y prevenir la diabetes de tipo 2"},"content":{"rendered":"<p>Investigadores del Programa de Epigen\u00e9tica y Biolog\u00eda del C\u00e1ncer del IDIBELL, dirigidos por Manel Esteller, participar\u00e1n en el proyecto europeo DEXLIFE que tiene como objetivo principal investigar nuevas v\u00edas de detectar y prevenir la diabetes tipo 2.<\/p>\n<p>El proyecto financiado con 5,5 millones de euros por la Uni\u00f3n Europea dentro el 7\u00ba Programa Marco de Investigaci\u00f3n y Desarrollo se desarrollar\u00e1 durante tres a\u00f1os y medio y contar\u00e1 con la participaci\u00f3n de cl\u00ednicos, investigadores b\u00e1sicos y empresas.<\/p>\n<p>DEXLIFE buscar\u00e1 biomarcadores gen\u00e9ticos, en sangre y en m\u00fasculo para establecer un mejor entendimiento de la progresi\u00f3n de pre-diabetes a diabetes tipo 2 y c\u00f3mo se puede prevenir.<\/p>\n<p>El proyecto DEXLIFE estar\u00e1 coordinado por Steno Diabetes de Dinamarca. EL IDIBELL ser\u00e1 el encargado de realizar los an\u00e1lisis epigen\u00e9ticos de c\u00e9lulas y tejidos. Los diez centros que participan en el DEXLIFE son:<\/p>\n<p>&nbsp;<\/p>\n<p>M\u00e1s informaci\u00f3n: <a class=\"enllac\" href=\"http:\/\/ec.europa.eu\/research\/health\/medical-research\/diabetes-and-obesity\/projects\/dexlife_en.html\" target=\"_blank\" rel=\"noopener noreferrer\">www.eu.europa.eu\/research<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Investigadores del Programa de Epigen\u00e9tica y Biolog\u00eda del C\u00e1ncer del IDIBELL, dirigidos por Manel Esteller, participar\u00e1n en el proyecto europeo DEXLIFE que tiene como objetivo principal investigar nuevas v\u00edas de detectar y prevenir la diabetes tipo 2. El proyecto financiado con 5,5 millones de euros por la Uni\u00f3n Europea dentro el 7\u00ba Programa Marco de [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":22195,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[286],"tags":[],"class_list":["post-11348","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-epigenetica-del-cancer-cancer"],"publishpress_future_action":{"enabled":false,"date":"2024-11-12 14:25:52","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/11348"}],"collection":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/comments?post=11348"}],"version-history":[{"count":2,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/11348\/revisions"}],"predecessor-version":[{"id":22196,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/11348\/revisions\/22196"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media\/22195"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media?parent=11348"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/categories?post=11348"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/tags?post=11348"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}